3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
2
Sarcoma
1
Genitourinary
1
Breast
1
Conditions
Breast Neoplasms
10
Hot Flashes
2
Anxiety Disorders
2
Vomiting
1
Testicular Germ Cell Tumor
1
Smoking Cessation
1
Sarcoma
1
Pathophobia
1
Pain
1
Ovarian Neoplasms
1
Nausea
1
Musculoskeletal Pain
1
Melanoma
1
Medication Adherence
1
Inflammatory Breast Neoplasms
1
Gastrointestinal Neoplasms
1
Emotional Regulation
1
Depression
1
Breast Carcinoma In Situ
1
Breast Cancer Surgery
1
Affective Symptoms
1
Interventions
pembrolizumab
42
Paclitaxel
26
Cyclophosphamide
25
Carboplatin
23
olaparib
21
Nivolumab
16
fludarabine
15
Docetaxel
13
aldesleukin
12
Gemcitabine
11
Fulvestrant
11
veliparib
9
Bevacizumab
9
sargramostim
8
palbociclib
8
durvalumab
8
Trastuzumab
8
Magnetic Resonance Spectroscopy
8
liposomal doxorubicin
7
atezolizumab
7
Surveys and Questionnaires
7
Ipilimumab
7
Blood Specimen Collection
7
niraparib
6
avelumab
6
Taxes
6
Specimen Handling
6
Interleukin-2
6
Fluorouracil
6
Cisplatin
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Ovarian Neoplasms
×
Hypnosis
×
Breast
×
Clear all
NCT07614620
2026-05-29
HYPNO-AJA2
Institut Bergonié
Phase NA
Not yet recruiting
70 enrolled